Close Menu

NEW YORK – Qiagen said on Thursday that it has concluded a syndicated revolving credit facility for €400 million (about $490 million) with an interest rate linked to the company's environmental, social, and governance performance.

The agreement, which was significantly oversubscribed by 11 banks, will run for three years, and each lender will be able to extend this period by a year twice. It replaces a facility of the same amount that runs until December 2021 and will be used for general corporate purposes including potential acquisitions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.